Cancer Disparities and Black American Representation in Clinical Trials Leading to the Approval of Oral Chemotherapy Drugs in the United States Between 2009 and 2019

Over the past 10 years, oral chemotherapy made up about half (45.6%) of all US Food and Drug Administration (FDA)–approved oncolytic and hematologic medications. Given the disparity in incidence and mortality rate because of certain cancers among Black Americans (BAs) in the United States, a review...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Oncol Pract
Main Authors: Ajewole, Veronica B., Akindele, Oyinkansola, Abajue, Uzoamaka, Ndulue, Okwuoma, Marshall, Jazzmin J., Mossi, Yhenew T.
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2021
Assuntos:
Special Series: Disparities in Cancer Care for Black People in the United States
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8120664/
https://ncbi.nlm.nih.gov/pubmed/33974825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/OP.20.01108
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados